glp 1 fda Wegovy Pill Wins Approval as First GLP-1 Oral Treatment for Obesity and Weight Loss How FDA's Action Against Non-FDA-Approved

The upside potential of these drugs is exciting, but challenges linked to safety, side effects, access, and adherence need to be overcome to achieve the full impacts we anticipate

HCV antibody, with reflex to HCV quantification by NAAT: preferred reflex test for screening and confirming HCV in at-risk individuals

In summary, genetic risk factors for development of serious DILI at relatively low levels of APAP overdose seem likely to exist but the limited studies performed to date need to be followed up by genome-wide approaches using larger numbers of confirmed DILI cases or possibly further studies on volunteers showing transient ALT elevation

Thats a message that resonates in the C-suite